Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study-Reference-Cited by-同舟云学术

Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study

Published:2022-11 Issue:2 Volume:160 Page:345-350
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Ali Ayesha S.,Lombardo Joseph,Niazi Muneeb Z,Miller Ryan C,Alnahhas Iyad,Martinez Nina L,Andrews David W.,Judy Kevin D,Shi Wenyin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-022-04146-w.pdf

Reference23 articles.

1. Stupp R et al “Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma,“N Engl J Med, vol. 352, no. 10, pp. 987 – 96, Mar 10 2005. https://doi.org/10.1056/NEJMoa043330

2. Network NCC “Central Nervous System Cancers (Version: 2.2021).“ [Online]. Available: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425

3. Stupp R et al (May 2009) “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial,“. Lancet Oncol 10(5):459–466. https://doi.org/10.1016/S1470-2045(09)70025-7

4. Stupp R et al “Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial,“ JAMA, vol. 314, no. 23, pp. 2535-43, Dec 15 2015. https://doi.org/10.1001/jama.2015.16669

5. Stupp R et al “Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial,“ JAMA, vol. 318, no. 23, pp. 2306–2316, Dec 19 2017. https://doi.org/10.1001/jama.2017.18718

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of stereotactic radiotherapy followed by bevacizumab and temozolomide in the treatment of recurrent glioblastoma: a case report;Frontiers in Pharmacology;2024-09-04

2. EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma;International Immunopharmacology;2024-09

3. Experience about Chemoradiation treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Newly Diagnosed Glioblastoma (GBM) Patients in China;2024-05-08

4. Distant recurrence in the cerebellar dentate nucleus through the dentato-rubro-thalamo-cortical pathway in supratentorial glioma cases;Acta Neurochirurgica;2024-02-14

5. Impact of transducer arrays on deep-site dosimetry in radiotherapy with concurrent TTFields for glioblastoma (extreme analysis);2024-02-07